arrow
N

Niklas Worm Andersson

Statens Serum Institut
H指数:18
被引数:1,245

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data

含新型冠状病毒肺炎mRNA的单价XBB.1.5疫苗在丹麦、芬兰和瑞典的比较有效性: 基于注册数据的目标试验模拟

2024-11-171
OAAI
COVID-19 Vaccine Effectiveness Among Adolescents
2024-01-103
PRE
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Postacute Risk of Non-Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged=50 Years

新型冠状病毒 (SARS-CoV-2) 感染和非冠状病毒病的急性后风险2019传染病住院: 丹麦50岁成年人的全国性队列研究

2023-09-220
OA
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses

在北欧国家omicron占主导地位期间,针对严重新型冠状病毒肺炎的异源第三剂量疫苗方案的比较有效性: 基于人群的队列分析

2023-07-2416
OAAI